A new medicine for treat diabetes
Application number Application date: April 22, 2002.
Release (announcement)No. CN 14 13624a Date of release (announcement): April 30, 2003.
The current legal status has no right to revoke its validity.
Classification number a 61k 35/78; A6 1P3/ 10
Applicant (patentee) Wu Changlai;
Address 4710/3 No.3 Longxi Living Area, Luoyang Institute of Technology, Luoyang City, Henan Province-1- 102
Inventor (Designer) Wu Changlai
right of priority
Patent agent
abstract
A new medicine for treating diabetes. Does not contain any chemical hypoglycemic substances, and is pure natural, non-toxic and has no side effects. It can block the invasion of harmful substances on islet cells, detoxify islet cells, promote islet cell regeneration, and restore the normal relationship between promotion and inhibition of islet cells, thus achieving the purpose of curing diabetes. Good curative effect, quick response and convenient use. After 16 years of research and clinical verification, the effective rate is as high as 98% and the cure rate is as high as 40%, which is a precedent for curing diabetes and has been highly praised by the majority of diabetic patients.